tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

JNJJohnson & Johnson

Health care · Pharmaceuticals · NYSE
Compare with peers → Embed

What JNJ's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Facts only; most of these sales are routine, such as selling shares from vesting stock awards.

Trading plans adopted or ended

InsiderWhatDateSharesRuns toReported in
Peter Fasolo
Executive Vice President, Chief Human Resources Officer
Adopted 10b5-1 plan Aug 31, 2023 up to 25,000 456 days 10-Q Oct 27, 2023
The company's description
On August 31, 2023, Peter Fasolo, Executive Vice President, Chief Human Resources Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) for the sale of up to 25,000 shares of the Company’s Common Stock, subject to certain conditions. The arrangement's expiration date is November 29, 2024.

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 28, 2023.

Form 144 notices of planned sales

FiledSellerSharesValueShares came from10b5-1 planForm 4 sales after
Sep 2, 2026 Schmid Timothy
Officer
33,597 $9,230,440 Stock Option Exercise none given 33,597 shares from Sep 2, 2026
Aug 17, 2026 Taubert Jennifer L
Officer
15,000 $3,950,418 Stock Option Exercise none given 15,000 shares from Aug 17, 2026
Aug 13, 2026 Duato Joaquin
Officer, Director
123,291 $32,199,927 Stock Option Exercise none given 123,291 shares from Aug 13, 2026
Aug 6, 2026 Forminard Elizabeth
Officer
15,918 $4,090,957 Restricted Stock Vesting; Stock Option Exercise none given 15,918 shares from Aug 6, 2026
Aug 5, 2026 Joaquin Duato
CEO, Chariman
48,480 $12,359,006 Executive compensation none given 171,771 shares from Aug 5, 2026
Jul 20, 2026 Broadhurst Vanessa
Officer
23,054 $5,792,689 Stock Option Exercise none given 23,054 shares from Jul 20, 2026
Jun 11, 2026 Wengel Kathryn E
Officer
10,000 $2,401,539 Stock Option Exercise none given 10,000 shares from Jun 11, 2026
Feb 27, 2026 Decker Robert J
Officer
4,075 $1,010,070 Option Granted - 02/13/2017 none given none found
Feb 20, 2026 Schmid Timothy
Officer
1,322 $324,763 Restricted Stock Vesting none given none found
Feb 18, 2026 Schmid Timothy
Officer
22,623 $5,527,546 Option Granted - 02/12/2018; Option Granted - 02/13/2017 none given none found
Feb 17, 2026 Broadhurst Vanessa
Officer
6,197 $1,508,300 Restricted Stock Vesting none given none found
Feb 17, 2026 Swanson James D.
Officer
20,521 $4,980,510 Options Granted - 02/08/2021 none given none found
Feb 17, 2026 Wolk Joseph J
Officer
89,654 $21,767,965 Options Granted - 02/11/2019; Options Granted - 02/12/2018; Options Granted - 02/13/2017; Restricted Stock Vesting none given none found
Feb 17, 2026 REED JOHN C
Officer
53,931 $13,105,233 Options Granted - 02/15/2024; Options Granted - 02/15/2025; Restricted Stock Vesting none given none found
Feb 13, 2026 Swanson James D.
Officer
41,559 $10,129,246 Option Granted - 02/13/2023; Option Granted - 02/14/2022 none given none found
Feb 5, 2026 Forminard Elizabeth
Officer
6,226 $1,481,195 Option Granted - 02/12/2018 none given none found
Jan 26, 2026 Joaquin Duato
CEO, Chariman
100,000 $22,014,000 Transfer none given none found

From the Form 144 XML filed with the SEC, since Jan 26, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Next Owners →

Work on JNJ in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/JNJ/export.csv") into a cell.